About Index Trending news
Analyze
Top 50 Pricing
Northwest Biotherapeutics

Northwest Biotherapeutics

Work at Northwest Biotherapeutics? Add yourself to this profile

Northwest Biotherapeutics

NW Bio is a biotech company developing immune therapies (DCVax®) to treat a broad range of cancers including brain, prostate & ovarian.

Elsewhere

Alexa global traffic share

Twitter followers

15 Mar 2016
$10,000,000
Post-IPO debt

SEC FORM D

sec
03 Apr 2015
$40,000,000
Post-IPO equity
20 Nov 2014
$35,000,000
Post-IPO equity
07 Oct 2014
$11,500,000
Post-IPO equity
26 Nov 2013
$27,000,000
Post-IPO equity
09 Dec 2010
$395,000
Venture capital